Aluminum-associated bone disease: considerations on the pathogenesis and the effects of deferoxamine treatment.
作者信息
Kurokawa K, Marumo F, Ogura Y, Ono T, Suzuki M
出版信息
J UOEH. 1987 Mar 20;9 Suppl:133-9.
PMID:3602744
Abstract
摘要
相似文献
1
Aluminum-associated bone disease: considerations on the pathogenesis and the effects of deferoxamine treatment.铝相关性骨病：关于发病机制及去铁胺治疗效果的思考
J UOEH. 1987 Mar 20;9 Suppl:133-9.
2
3
Rapid conversion from aluminium bone disease to hyperparathyroid bone disease by desferrioxamine.去铁胺使铝骨病迅速转变为甲状旁腺功能亢进性骨病。
Nihon Jinzo Gakkai Shi. 1988 Sep;30(9):1129-33.
4
5
Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease.用去铁胺治疗铝相关性骨病引发透析性痴呆
Am J Kidney Dis. 1988 Aug;12(2):126-30. doi: 10.1016/s0272-6386(88)80007-6.
6
The use of desferrioximine in dialysis-associated aluminium disease.
Contrib Nephrol. 1993;102:125-34. doi: 10.1159/000421919.
7
The efficacy of various treatment modalities on aluminium associated bone disease.
Proc Eur Dial Transplant Assoc. 1983;19:195-202.
8
Aluminum and iron overload in chronic dialysis.慢性透析中的铝和铁过载
Kidney Int Suppl. 1988 Mar;24:S163-7.
9
Encephalopathy in chronic renal failure responsive to deferoxamine therapy. Another manifestation of aluminum neurotoxicity.慢性肾衰竭中的脑病对去铁胺治疗有反应。铝神经毒性的另一种表现。
Arch Intern Med. 1986 Oct;146(10):2063-4.
10
Osteomalacia and bone disease arising from aluminum.
Semin Nephrol. 1986 Mar;6(1):68-89.
Zotero 插件